7,152 Shares in DaVita Inc. $DVA Acquired by Westwind Capital

Key Points

• Westwind Capital acquired 7,152 DaVita shares during the third quarter, valued at approximately $1.25 million. Institutional investors collectively own 90.12% of the company.
• Analysts maintain a cautious outlook, with three Buy ratings and four Hold ratings, producing a consensus “Hold” rating and an average price target of $233.43.
• DaVita reported quarterly EPS of $4.02, beating estimates of $3.88, while revenue rose 5.2% year over year to $3.55 billion. The stock recently traded at $176.44, well below its 52-week high of $247.49.

Westwind Capital purchased a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 7,152 shares of the company's stock, valued at approximately $1,251,000.

Several other hedge funds have also made changes to their positions in the stock. CoreCap Advisors LLC grew its stake in DaVita by 161.7% during the 3rd quarter. CoreCap Advisors LLC now owns 157 shares of the company's stock worth $27,000 after buying an additional 97 shares during the last quarter. Root Financial Partners LLC increased its holdings in shares of DaVita by 128.0% in the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company's stock worth $29,000 after acquiring an additional 105 shares during the period. Compass Financial Management LLC bought a new stake in DaVita in the 2nd quarter valued at about $72,000. Sankala Group LLC acquired a new position in DaVita during the 4th quarter valued at about $39,000. Finally, NewEdge Advisors LLC grew its position in DaVita by 66.4% in the 2nd quarter. NewEdge Advisors LLC now owns 361 shares of the company's stock worth $80,000 after purchasing an additional 144 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wall Street Zen downgraded DaVita from a "buy" rating to a "hold" rating in a research report on Saturday, September 26th. Raymond James Financial set a $220.00 target price on DaVita in a research note on Friday, August 7th. UBS Group boosted their price target on DaVita from $235.00 to $270.00 and gave the stock a "buy" rating in a research report on Friday, July 10th. Oppenheimer set a $220.00 price target on DaVita in a research note on Friday, August 7th. Finally, Barclays lifted their price objective on shares of DaVita from $218.00 to $224.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, DaVita currently has a consensus rating of "Hold" and an average target price of $233.43.

DaVita Price Performance

Shares of DaVita stock traded down $0.34 during trading on Thursday, hitting $176.44. The stock had a trading volume of 582,204 shares, compared to its average volume of 901,968. The business has a fifty day moving average of $184.82 and a two-hundred day moving average of $189.41. DaVita Inc. has a fifty-two week low of $101.00 and a fifty-two week high of $247.49. The firm has a market cap of $11.26 billion, a P/E ratio of 14.44, a PEG ratio of 0.47 and a beta of 0.80.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $4.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.88 by $0.14. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The firm had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.50 billion. During the same period in the previous year, the company earned $2.95 earnings per share. DaVita's revenue was up 5.2% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, research analysts forecast that DaVita Inc. will post 14.57 earnings per share for the current year.

DaVita Profile

DaVita Inc is a healthcare company focused on kidney care and renal disease management. Through its DaVita Kidney Care business, the company provides outpatient dialysis treatments for people with end-stage kidney disease, including hemodialysis and peritoneal dialysis, as well as home dialysis support.

The company also operates hospital-based dialysis programs and offers clinical, administrative and care-coordination services intended to support patients across the kidney-care journey.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.